Apart from this negative oncological impact that platelet activation has in cancer, various studies clearly demonstrate that, in many types of cancer, the release of proinflammatory cytokines, such as IL-1, IL-3, and IL-6, clearly promotes megakaryocytes' proliferation, resulting in the gradual establishment of thrombocytosis [14, 15]. Here, IL6 is linked to cancer.